PROLOGUE - REG(EPA:ALPRG) stock Fundamental Analysis

Fundamental Rating

Taking everything into account, ALPRG scores 3 out of 10 in our fundamental rating. ALPRG was compared to 99 industry peers in the Software industry. ALPRG has a bad profitability rating. Also its financial health evaluation is rather negative. ALPRG is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year ALPRG has reported negative net income.

In the past year ALPRG had a positive cash flow from operations.

ALPRG had negative earnings in 4 of the past 5 years.

In the past 5 years ALPRG always reported a positive cash flow from operatings.

1.2 Ratios

The Return On Assets of ALPRG (-14.66%) is worse than 74.75% of its industry peers.

ALPRG has a worse Return On Equity (-75.61%) than 77.78% of its industry peers.

The Return On Invested Capital of ALPRG (1.51%) is comparable to the rest of the industry.

		Industry Rank	Sector Rank
ROA	-14.66%
ROE	-75.61%
ROIC	1.51%

ROA(3y)-5%

ROA(5y)-3.68%

ROE(3y)-25.62%

ROE(5y)-19.99%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Operating Margin of ALPRG (0.63%) is comparable to the rest of the industry.

ALPRG's Operating Margin has declined in the last couple of years.

ALPRG has a better Gross Margin (80.23%) than 73.74% of its industry peers.

In the last couple of years the Gross Margin of ALPRG has grown nicely.

		Industry Rank	Sector Rank
OM	0.63%
PM (TTM)	N/A
GM	80.23%

OM growth 3Y10.31%

OM growth 5Y-27.28%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y13.04%

GM growth 5Y5.76%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ALPRG has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.

ALPRG has about the same amout of shares outstanding than it did 1 year ago.

Compared to 5 years ago, ALPRG has more shares outstanding

The debt/assets ratio for ALPRG is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of 1.48, we must say that ALPRG is in the distress zone and has some risk of bankruptcy.

ALPRG's Altman-Z score of 1.48 is on the low side compared to the rest of the industry. ALPRG is outperformed by 60.61% of its industry peers.

ALPRG has a debt to FCF ratio of 4.22. This is a neutral value as ALPRG would need 4.22 years to pay back of all of its debts.

The Debt to FCF ratio of ALPRG (4.22) is comparable to the rest of the industry.

ALPRG has a Debt/Equity ratio of 0.65. This is a neutral value indicating ALPRG is somewhat dependend on debt financing.

Looking at the Debt to Equity ratio, with a value of 0.65, ALPRG is doing worse than 71.72% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.65
Debt/FCF	4.22
Altman-Z	1.48

ROIC/WACC0.2

WACC7.6%

2.3 Liquidity

ALPRG has a Current Ratio of 1.16. This is a normal value and indicates that ALPRG is financially healthy and should not expect problems in meeting its short term obligations.

ALPRG has a Current ratio (1.16) which is comparable to the rest of the industry.

A Quick Ratio of 1.16 indicates that ALPRG should not have too much problems paying its short term obligations.

The Quick ratio of ALPRG (1.16) is comparable to the rest of the industry.

		Industry Rank	Sector Rank
Current Ratio	1.16
Quick Ratio	1.16

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for ALPRG have decreased strongly by -1733.82% in the last year.

Looking at the last year, ALPRG shows a small growth in Revenue. The Revenue has grown by 3.05% in the last year.

The Revenue has been growing slightly by 5.37% on average over the past years.

EPS 1Y (TTM)-1733.82%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-772.13%

Revenue 1Y (TTM)3.05%

Revenue growth 3Y12.14%

Revenue growth 5Y5.37%

Sales Q2Q%-2%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

The Revenue is expected to grow by 6.31% on average over the next years.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year5.58%

Revenue Next 2Y14.42%

Revenue Next 3Y6.31%

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALPRG. In the last year negative earnings were reported.

ALPRG is valuated quite expensively with a Price/Forward Earnings ratio of 29.02.

60.61% of the companies in the same industry are more expensive than ALPRG, based on the Price/Forward Earnings ratio.

The average S&P500 Price/Forward Earnings ratio is at 22.10. ALPRG is valued slightly more expensive when compared to this.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	29.02

4.2 Price Multiples

94.95% of the companies in the same industry are more expensive than ALPRG, based on the Enterprise Value to EBITDA ratio.

Based on the Price/Free Cash Flow ratio, ALPRG is valued cheaply inside the industry as 96.97% of the companies are valued more expensively.

		Industry Rank	Sector Rank
P/FCF	7.53
EV/EBITDA	4.21

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for ALPRG!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

PROLOGUE - REG

EPA:ALPRG (3/7/2025, 7:00:00 PM)

0.284

+0.01 (+4.41%)

Chartmill FA Rating

GICS SectorInformation Technology

GICS IndustryGroupSoftware & Services

GICS IndustrySoftware

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst OwnersN/A

Inst Owner ChangeN/A

Ins Owners2.71%

Ins Owner ChangeN/A

Market Cap28.56M

AnalystsN/A

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	29.02
P/S	0.26
P/FCF	7.53
P/OCF	4.45
P/B	2.12
P/tB	N/A
EV/EBITDA	4.21

EPS(TTM)-0.11

EYN/A

EPS(NY)0.01

Fwd EY3.45%

FCF(TTM)0.04

FCFY13.29%

OCF(TTM)0.06

OCFY22.5%

SpS1.11

BVpS0.13

TBVpS-0.07

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-14.66%
ROE	-75.61%
ROCE	2.06%
ROIC	1.51%
ROICexc	2.42%
ROICexgc	67.67%
OM	0.63%
PM (TTM)	N/A
GM	80.23%
FCFM	3.4%

ROA(3y)-5%

ROA(5y)-3.68%

ROE(3y)-25.62%

ROE(5y)-19.99%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3Y231.27%

ROICexcg growth 5Y12.99%

ROICexc growth 3Y53.31%

ROICexc growth 5Y-16.55%

OM growth 3Y10.31%

OM growth 5Y-27.28%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y13.04%

GM growth 5Y5.76%

F-Score4

Asset Turnover1.6

Health

		Industry Rank	Sector Rank
Debt/Equity	0.65
Debt/FCF	4.22
Debt/EBITDA	1.16
Cap/Depr	38.56%
Cap/Sales	2.35%
Interest Coverage	250
Cash Conversion	85.33%
Profit Quality	N/A
Current Ratio	1.16
Quick Ratio	1.16
Altman-Z	1.48

F-Score4

WACC7.6%

ROIC/WACC0.2

Cap/Depr(3y)80.33%

Cap/Depr(5y)77.94%

Cap/Sales(3y)3.41%

Cap/Sales(5y)4.32%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-1733.82%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-772.13%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)3.05%

Revenue growth 3Y12.14%

Revenue growth 5Y5.37%

Sales Q2Q%-2%

Revenue Next Year5.58%

Revenue Next 2Y14.42%

Revenue Next 3Y6.31%

Revenue Next 5YN/A

EBIT growth 1Y-62.46%

EBIT growth 3Y23.71%

EBIT growth 5Y-23.37%

EBIT Next Year319.85%

EBIT Next 3Y79.08%

EBIT Next 5YN/A

FCF growth 1Y505.78%

FCF growth 3Y35.68%

FCF growth 5Y90.81%

OCF growth 1Y87.02%

OCF growth 3Y14.63%

OCF growth 5Y10.14%

PROLOGUE - REG (ALPRG.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens